From a performance-recovery perspective, cell studies suggest BPC-157 can up-regulate the growth-hormone receptor in tendon fibroblastspotentially priming tissue for remodeling alongside rehab
HIF-1, Hypoxia inducible factor-1
They range from mild to debilitating and life-threatening
Increases insulin secretion Suppresses appetite BPC-157: Accelerated wound healing Decreases inflammation Increased fibroblast Nitric oxide improvement Improves digestive function Enhanced vascular expression of VEGFR2 Prescribing Protocol: Inject 0.1cc (.25mg) subcutaneously once per week
Administration via injection or IV Drip under sterile, medical supervision
Final Word: Awareness Before Experimentation As interest in biohacking, regenerative medicine, and peptide therapy grows, patients need to know that not all that glitters is gold or sterile